https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2017-10-02 17:34:182022-08-25 17:02:31La stipsi cronica idiopatica
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2017-10-02 17:22:352022-08-25 17:01:33Lactobacillus Sepsis Associated With Probiotic Therapy
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2017-09-29 16:35:492022-08-25 17:00:49Antibacterial Activity of Lactoferrin and a Pepsin-Derived Lactoferrin Peptide Fragment
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2017-09-29 15:56:212022-08-25 17:00:10La stabilità genetica del Lactobacillus paracasei subsp. paracasei F19
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2017-09-29 15:50:322022-08-25 16:59:33Lactobacillus Paracasei subsp. Paracasei F19; a farmacogenomic and clinical update
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2016-10-19 15:20:062022-08-25 16:58:32The microbiome and dermatological diseases
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2016-10-19 15:16:092022-08-25 16:57:41The skin microbiome
https://www.farmagens.it/wp-content/uploads/2021/03/PUBBLICAZIONI9.2.png
94
95
julia_l
https://www.farmagens.it/wp-content/uploads/2022/04/logo.jpg
julia_l2016-05-12 15:06:102022-05-24 14:39:28Farmagens Health Care assegna ad un team di ricercatori Italiani e Americani la Borsa di Studio per l’anno 2016
